{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T09:43:03Z","timestamp":1792575783457,"version":"4.5.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T00:00:00Z","timestamp":1792540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T00:00:00Z","timestamp":1792540800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100011912","name":"Taipei Veterans General Hospital","doi-asserted-by":"publisher","award":["V115C-021"],"award-info":[{"award-number":["V115C-021"]}],"id":[{"id":"10.13039\/501100011912","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011912","name":"Taipei Veterans General Hospital","doi-asserted-by":"publisher","award":["V115B-022"],"award-info":[{"award-number":["V115B-022"]}],"id":[{"id":"10.13039\/501100011912","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005382","name":"National Yang-Ming University","doi-asserted-by":"publisher","award":["114-V-B-079"],"award-info":[{"award-number":["114-V-B-079"]}],"id":[{"id":"10.13039\/501100005382","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["114-2314-B-A49-034"],"award-info":[{"award-number":["114-2314-B-A49-034"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["114-2314-B-075-020-MY2"],"award-info":[{"award-number":["114-2314-B-075-020-MY2"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1007\/s00415-026-14193-2","type":"journal-article","created":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T09:07:25Z","timestamp":1792573645000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical performance and decision thresholds of an automated plasma p-tau217 assay for amyloid pathology in a Taiwanese memory clinic"],"prefix":"10.1007","volume":"273","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3170-5516","authenticated-orcid":false,"given":"Yung-Shuan","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng-Ju","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chien-Liang","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsiang-Ling","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9135-3351","authenticated-orcid":false,"given":"Jong-Ling","family":"Fuh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,21]]},"reference":[{"key":"14193_CR1","doi-asserted-by":"publisher","first-page":"5143","DOI":"10.1002\/alz.13859","volume":"20","author":"CR Jack","year":"2024","unstructured":"Jack CR, Andrews JS, Beach TG et al (2024) Revised criteria for diagnosis and staging of Alzheimer\u2019s disease: Alzheimer\u2019s Association Workgroup. Alzheimers Dement J Alzheimers Assoc 20:5143\u20135169. https:\/\/doi.org\/10.1002\/alz.13859","journal-title":"Alzheimers Dement J Alzheimers Assoc"},{"key":"14193_CR2","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1016\/S0140-6736(25)01294-2","volume":"406","author":"GB Frisoni","year":"2025","unstructured":"Frisoni GB, Hansson O, Nichols E et al (2025) New landscape of the diagnosis of Alzheimer\u2019s disease. Lancet 406:1389\u20131407. https:\/\/doi.org\/10.1016\/S0140-6736(25)01294-2","journal-title":"Lancet"},{"key":"14193_CR3","doi-asserted-by":"publisher","DOI":"10.1002\/alz.14528","volume":"21","author":"A Leuzy","year":"2025","unstructured":"Leuzy A, Bollack A, Pellegrino D et al (2025) Considerations in the clinical use of amyloid PET and CSF biomarkers for Alzheimer\u2019s disease. Alzheimers Dement J Alzheimers Assoc 21:e14528. https:\/\/doi.org\/10.1002\/alz.14528","journal-title":"Alzheimers Dement J Alzheimers Assoc"},{"key":"14193_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2026.103058","volume":"117","author":"W Fu","year":"2026","unstructured":"Fu W, Ho PC-L (2026) Blood-based biomarkers for Alzheimer\u2019s disease: advances in early detection and monitoring of age-related neurodegeneration. Aging Res Rev 117:103058. https:\/\/doi.org\/10.1016\/j.arr.2026.103058","journal-title":"Aging Res Rev"},{"key":"14193_CR5","doi-asserted-by":"publisher","DOI":"10.1002\/alz.14508","volume":"21","author":"NJ Ashton","year":"2025","unstructured":"Ashton NJ, Keshavan A, Brum WS et al (2025) The Alzheimer\u2019s Association Global Biomarker Standardization Consortium (GBSC) plasma phospho-tau round robin study. Alzheimers Dement J Alzheimers Assoc 21:e14508. https:\/\/doi.org\/10.1002\/alz.14508","journal-title":"Alzheimers Dement J Alzheimers Assoc"},{"key":"14193_CR6","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/S1474-4422(21)00214-3","volume":"20","author":"EH Thijssen","year":"2021","unstructured":"Thijssen EH, La Joie R, Strom A et al (2021) Plasma phosphorylated p-tau217 and phosphorylated tau 181 as biomarkers in Alzheimer\u2019s disease and frontotemporal lobar degeneration: a retrospective diagnostic performance study. Lancet Neurol 20:739\u2013752. https:\/\/doi.org\/10.1016\/S1474-4422(21)00214-3","journal-title":"Lancet Neurol"},{"key":"14193_CR7","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1093\/brain\/awac333","volume":"146","author":"S Janelidze","year":"2023","unstructured":"Janelidze S, Bali D, Ashton NJ et al (2023) Head-to-head comparison of 10 plasma phospho-tau assays in prodromal Alzheimer\u2019s disease. Brain J Neurol 146:1592\u20131601. https:\/\/doi.org\/10.1093\/brain\/awac333","journal-title":"Brain J Neurol"},{"key":"14193_CR8","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.1007\/s00415-023-12148-5","volume":"271","author":"AJ Mendes","year":"2024","unstructured":"Mendes AJ, Ribaldi F, Lathuiliere A et al (2024) Head-to-head study of diagnostic accuracy of plasma and cerebrospinal fluid p-tau217 versus p-tau181 and p-tau231 in a memory clinic cohort. J Neurol 271:2053\u20132066. https:\/\/doi.org\/10.1007\/s00415-023-12148-5","journal-title":"J Neurol"},{"key":"14193_CR9","doi-asserted-by":"publisher","DOI":"10.1002\/alz.71009","volume":"22","author":"DP Hibar","year":"2026","unstructured":"Hibar DP, Bauer A, Rabe C et al (2026) Elecsys p-tau217 plasma immunoassay detection of amyloid pathology in clinical cohorts. Alzheimers Dement 22:e71009. https:\/\/doi.org\/10.1002\/alz.71009","journal-title":"Alzheimers Dement"},{"key":"14193_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.tjpad.2026.100534","volume":"13","author":"S Hortsch","year":"2026","unstructured":"Hortsch S, Domenico AD, Borlinghaus N et al (2026) Performance of a fully automated plasma p-tau217 immunoassay to reflect amyloid-beta burden in an unselected cohort representative of clinical practice. J Prev Alzheimers Dis 13:100534. https:\/\/doi.org\/10.1016\/j.tjpad.2026.100534","journal-title":"J Prev Alzheimers Dis"},{"key":"14193_CR11","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000210287","volume":"104","author":"JA Bornhorst","year":"2025","unstructured":"Bornhorst JA, Lundgreen CS, Weigand SD et al (2025) Quantitative assessment of the effect of chronic kidney disease on plasma p-tau217 concentrations. Neurology 104:e210287. https:\/\/doi.org\/10.1212\/WNL.0000000000210287","journal-title":"Neurology"},{"key":"14193_CR12","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1001\/jamaneurol.2023.0199","volume":"80","author":"S Janelidze","year":"2023","unstructured":"Janelidze S, Barth\u00e9lemy NR, He Y et al (2023) Mitigating the associations of kidney dysfunction with blood biomarkers of Alzheimer disease by using phosphorylated tau to total tau ratios. JAMA Neurol 80:516\u2013522. https:\/\/doi.org\/10.1001\/jamaneurol.2023.0199","journal-title":"JAMA Neurol"},{"key":"14193_CR13","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.1001\/archneur.58.12.1985","volume":"58","author":"RC Petersen","year":"2001","unstructured":"Petersen RC, Doody R, Kurz A et al (2001) Current concepts in mild cognitive impairment. Arch Neurol 58:1985\u20131992. https:\/\/doi.org\/10.1001\/archneur.58.12.1985","journal-title":"Arch Neurol"},{"key":"14193_CR14","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1037\/1040-3590.13.4.566","volume":"13","author":"DS Tulsky","year":"2001","unstructured":"Tulsky DS, Saklofske DH, Wilkins C, Weiss LG (2001) Development of a general ability index for the Wechsler Adult Intelligence Scale\u2014third edition. Psychol Assess 13:566\u2013571","journal-title":"Psychol Assess"},{"key":"14193_CR15","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","volume":"7","author":"GM McKhann","year":"2011","unstructured":"McKhann GM, Knopman DS, Chertkow H et al (2011) The diagnosis of dementia due to Alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease. Alzheimers Dement 7:263\u2013269. https:\/\/doi.org\/10.1016\/j.jalz.2011.03.005","journal-title":"Alzheimers Dement"},{"key":"14193_CR16","doi-asserted-by":"publisher","DOI":"10.1176\/appi.books.9780890425596","volume-title":"Diagnostic and statistical manual of mental disorders, fifth edition","author":"American Psychiatric Association","year":"2013","unstructured":"American Psychiatric Association (2013) Diagnostic and statistical manual of mental disorders, fifth edition. American Psychiatric Association"},{"key":"14193_CR17","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1007\/s40846-025-00972-1","volume":"45","author":"S-Y Huang","year":"2025","unstructured":"Huang S-Y, Lin K-J, Lyu Z-J, Hsiao I-T (2025) The development of an automatic amyloid PET quantification (AmPQ) software with MR-based and MR-free spatial normalization. J Med Biol Eng 45:492\u2013501. https:\/\/doi.org\/10.1007\/s40846-025-00972-1","journal-title":"J Med Biol Eng"},{"key":"14193_CR18","unstructured":"The Global Alzheimer\u2019s Association Interactive Network. https:\/\/www.gaain.org\/about\/. Accessed 7 June 2026"},{"key":"14193_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-020-00587-5","volume":"12","author":"S Amadoru","year":"2020","unstructured":"Amadoru S, Dor\u00e9 V, McLean CA et al (2020) Comparison of amyloid PET measured in Centiloid units with neuropathological findings in Alzheimer\u2019s disease. Alzheimers Res Ther 12:22. https:\/\/doi.org\/10.1186\/s13195-020-00587-5","journal-title":"Alzheimers Res Ther"},{"key":"14193_CR20","doi-asserted-by":"publisher","first-page":"3508","DOI":"10.1007\/s00259-022-05784-y","volume":"49","author":"HG Pemberton","year":"2022","unstructured":"Pemberton HG, Collij LE, Heeman F et al (2022) Quantification of amyloid PET for future clinical use: a state-of-the-art review. Eur J Nucl Med Mol Imaging 49:3508\u20133528. https:\/\/doi.org\/10.1007\/s00259-022-05784-y","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"14193_CR21","unstructured":"Roche Diagnostics (2024) Roche AD CSF Brochure."},{"key":"14193_CR22","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/j.jalz.2015.05.004","volume":"11","author":"LA Beckett","year":"2015","unstructured":"Beckett LA, Donohue MC, Wang C et al (2015) The Alzheimer\u2019s disease neuroimaging initiative 2: increasing the length, breadth, and depth of our understanding. Alzheimers Dement J Alzheimers Assoc 11:823\u2013831. https:\/\/doi.org\/10.1016\/j.jalz.2015.05.004","journal-title":"Alzheimers Dement J Alzheimers Assoc"},{"key":"14193_CR23","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1001\/jamaneurol.2023.5319","volume":"81","author":"NJ Ashton","year":"2024","unstructured":"Ashton NJ, Brum WS, Di Molfetta G et al (2024) Diagnostic accuracy of a plasma phosphorylated tau 217 immunoassay for Alzheimer disease pathology. JAMA Neurol 81:255\u2013263. https:\/\/doi.org\/10.1001\/jamaneurol.2023.5319","journal-title":"JAMA Neurol"},{"key":"14193_CR24","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1056\/NEJMoa2102953","volume":"385","author":"LA Inker","year":"2021","unstructured":"Inker LA, Eneanya ND, Coresh J et al (2021) New creatinine- and cystatin C-based equations to estimate GFR without race. N Engl J Med 385:1737\u20131749. https:\/\/doi.org\/10.1056\/NEJMoa2102953","journal-title":"N Engl J Med"},{"key":"14193_CR25","doi-asserted-by":"publisher","first-page":"S117","DOI":"10.1016\/j.kint.2023.10.018","volume":"105","author":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group","year":"2024","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group (2024) KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int 105:S117\u2013S314. https:\/\/doi.org\/10.1016\/j.kint.2023.10.018","journal-title":"Kidney Int"},{"key":"14193_CR26","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1001\/jamaneurol.2023.4596","volume":"81","author":"N Mattsson-Carlgren","year":"2024","unstructured":"Mattsson-Carlgren N, Collij LE, Stomrud E et al (2024) Plasma biomarker strategy for selecting patients with Alzheimer disease for antiamyloid immunotherapies. JAMA Neurol 81:69\u201378. https:\/\/doi.org\/10.1001\/jamaneurol.2023.4596","journal-title":"JAMA Neurol"},{"key":"14193_CR27","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1093\/brain\/awag001","volume":"149","author":"N Benina","year":"2026","unstructured":"Benina N, Buitrago L, De Simone FI et al (2026) Plasma p-tau217\/\u03b2-amyloid 1-42 ratio for enhanced accuracy and reduced uncertainty in detecting amyloid pathology. Brain 149:1168\u20131181. https:\/\/doi.org\/10.1093\/brain\/awag001","journal-title":"Brain"},{"key":"14193_CR28","doi-asserted-by":"publisher","first-page":"6506","DOI":"10.1002\/alz.14140","volume":"20","author":"DJ Figdore","year":"2024","unstructured":"Figdore DJ, Griswold M, Bornhorst JA et al (2024) Optimizing cutpoints for clinical interpretation of brain amyloid status using plasma p-tau217 immunoassays. Alzheimers Dement J Alzheimers Assoc 20:6506\u20136516. https:\/\/doi.org\/10.1002\/alz.14140","journal-title":"Alzheimers Dement J Alzheimers Assoc"},{"key":"14193_CR29","doi-asserted-by":"publisher","DOI":"10.1515\/cclm-2026-0395","author":"M Mart\u00ednez-Bujidos","year":"2026","unstructured":"Mart\u00ednez-Bujidos M, Men\u00e9ndez A, Pulido-Gracia JA et al (2026) Analytical agreement and platform-specific decision thresholds for plasma p-tau217 measured on Lumipulse G600II and Cobas e801 in a paired CSF-plasma cohort. Clin Chem Lab Med. https:\/\/doi.org\/10.1515\/cclm-2026-0395","journal-title":"Clin Chem Lab Med"},{"key":"14193_CR30","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1001\/jama.2020.12134","volume":"324","author":"S Palmqvist","year":"2020","unstructured":"Palmqvist S, Janelidze S, Quiroz YT et al (2020) Discriminative accuracy of plasma phospho-tau217 for Alzheimer disease vs other neurodegenerative disorders. JAMA 324:772\u2013781. https:\/\/doi.org\/10.1001\/jama.2020.12134","journal-title":"JAMA"},{"key":"14193_CR31","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1001\/jamaneurol.2025.5530","volume":"83","author":"J Yun","year":"2026","unstructured":"Yun J, Lee J, Shin D et al (2026) Plasma phosphorylated tau 217 cutoffs for amyloid pathology and kidney function, body mass index, and anemia. JAMA Neurol 83:269\u2013279. https:\/\/doi.org\/10.1001\/jamaneurol.2025.5530","journal-title":"JAMA Neurol"},{"key":"14193_CR32","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-025-01692-z","volume":"17","author":"B Arslan","year":"2025","unstructured":"Arslan B, Brum WS, Pola I et al (2025) The impact of kidney function on Alzheimer\u2019s disease blood biomarkers: implications for predicting amyloid-\u03b2 positivity. Alzheimers Res Ther 17:48. https:\/\/doi.org\/10.1186\/s13195-025-01692-z","journal-title":"Alzheimers Res Ther"},{"key":"14193_CR33","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2023.1150510","volume":"15","author":"B Zhang","year":"2023","unstructured":"Zhang B, Zhang C, Wang Y et al (2023) Effect of renal function on the diagnostic performance of plasma biomarkers for Alzheimer\u2019s disease. Front Aging Neurosci 15:1150510. https:\/\/doi.org\/10.3389\/fnagi.2023.1150510","journal-title":"Front Aging Neurosci"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-026-14193-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-026-14193-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-026-14193-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T09:07:28Z","timestamp":1792573648000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-026-14193-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,21]]},"references-count":33,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["14193"],"URL":"https:\/\/doi.org\/10.1007\/s00415-026-14193-2","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,21]]},"assertion":[{"value":"26 August 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests. The Roche plasma assays were purchased using institutional or investigator-initiated research funds. Roche Diagnostics did not provide plasma assay kits, reagents, funding, or in-kind support for this study and had no role in the study design; data collection, analysis, or interpretation; drafting or revision of the manuscript; or the decision to submit the article for publication.","order":1,"name":"Ethics","label":"Conflicts of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Institutional Review Board of Taipei Veterans General Hospital (2012\u201305-033B; 2022\u201301-005ACF) and was conducted in accordance with the Declaration of Helsinki.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent was obtained from all participants or their legal representatives.","order":3,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"674"}}